These observations are consistent with frequent overexpression of AURKA and HMMR in BRCA1-mutant breast cancer cell lines and tumors10,11, and suggest that abnormal earlier localization of ARPC2 at mitotic spindle poles is mediated by overexpression of HMMR that triggers AURKA overactivation. The gene discussed is ARPC2; the disease is breast cancer.